Brett Kaplan's Net Worth

$0

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Brett Kaplan?

Brett Kaplan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prevail Therapeutics Inc., Compass Therapeutics, Inc., and Eliem Therapeutics, Inc..

SEC CIK

Brett Kaplan's CIK is 0001778763

Past Insider Trading and Trends

2020 was Brett Kaplan's most active year for acquiring shares with 2 total transactions. Brett Kaplan's most active month to acquire stocks was the month of January. 2021 was Brett Kaplan's most active year for disposing of shares, totalling 3 transactions. Brett Kaplan's most active month to dispose stocks was the month of December. 2024 saw Brett Kaplan paying a total of $0.00 for 542,500 shares, this is the most they've acquired in one year. In 2021 Brett Kaplan cashed out on 506,569 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prevail Therapeutics Inc. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Feb 19
Form 3
—
0
—
—
0
No matching records found

Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 18
Form 4
—
0
—
—
0
Sep 10
Form 3
—
0
—
—
0
No matching records found

Eliem Therapeutics, Inc. (ELYM) Snapshot price: $7.39

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 26
Form 3
—
0
—
—
0
No matching records found